Beckman Coulter will use the platform to unify data across its instruments and systems to provide standardized performance metrics and AI-based analytics.

Last week, readers were most interested in a story about Dxcover's platform, which integrates infrared spectroscopy with proprietary algorithms, receiving Class C certification.

The Irvine, California-based company will now market its test to clinical labs throughout the UK for patient testing.

The system consists of a microfluidic cartridge with 640 incubation wells that allows the platform to visually test all clinically relevant antibiotics quantitatively.

The firm expects to reach patients who might otherwise avoid medical appointments by offering screening tests through dentists.

The Phase II study will evaluate CytoDyn's leronlimab in combination with TAS-102 and bevacizumab in patients with relapsed or refractory metastatic colorectal cancer.

The platform analyzes infrared spectroscopy data from a small sample of blood with proprietary algorithms to detect cancer early.

The award supports development of a portable test system using the firm's protein nucleic acid probes and semiconductor sensor tech.

The software is designed to analyze digital pathology whole-slide images of skin lesions and aid pathologists in their review.